Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313463607> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4313463607 abstract "Abstract Background: Even though chemotherapy-induced nausea and vomiting (CINV) can be well controlled in the acute phase, the incidence of delayedCINV remains high. In this study, we intend to investigate whether prolonged use of NK-1 receptor antagonist (RA) in addition to 5-HT3 RA and dexamethasone (DEX) was more effective in preventing delayed CINV. Methods: This study was designed to compare the efficacy and safetyof fosaprepitant 150 mg given on days 1,3 (prolonged group) versus on day 1 (regular group) in patients receiving highly emetogenic chemotherapy (HEC). All patients also treated withpalonosetron on day 1 and DEX on days 1-3. The primary endpoint was the incidence of delayed nausea and vomiting. The second endpoint was related AEs. All the above endpoints were defined according to CTCAE 5.0. Results: Seventy-seven patients were randomly assigned to prolonged group and seventy-nine to regular group. Prolonged group demonstrated superiority in controlling delayed CINV to regular group, with statistically significant lower incidence of nausea (6.17% vs 12.66%, P=0.0056), and slightly lower incidence of grade 1 vomiting (1.62% vs 3.80%, P=0.0953) in the delayed phase. In addition, prolonged use of fosaprepitant was safe. No significant difference was found between the two groups regarding constipation, diarrhea, hiccough, fatigue, palpitation and headache in delayed phase. Conclusions: Prolonged use of fosaprepitant can effectively and safely prevent delayed CINV in patients receiving HEC." @default.
- W4313463607 created "2023-01-06" @default.
- W4313463607 creator A5002461253 @default.
- W4313463607 creator A5019840134 @default.
- W4313463607 creator A5034266315 @default.
- W4313463607 creator A5034452160 @default.
- W4313463607 creator A5036948844 @default.
- W4313463607 creator A5042451856 @default.
- W4313463607 creator A5050077108 @default.
- W4313463607 creator A5056676767 @default.
- W4313463607 creator A5069311354 @default.
- W4313463607 creator A5073746039 @default.
- W4313463607 date "2023-01-03" @default.
- W4313463607 modified "2023-09-30" @default.
- W4313463607 title "Prolonged usage of fosaprepitant for prevention of delayed CINV in patients receiving highly emetogenic chemotherapy" @default.
- W4313463607 doi "https://doi.org/10.21203/rs.3.rs-1737681/v2" @default.
- W4313463607 hasPublicationYear "2023" @default.
- W4313463607 type Work @default.
- W4313463607 citedByCount "0" @default.
- W4313463607 crossrefType "posted-content" @default.
- W4313463607 hasAuthorship W4313463607A5002461253 @default.
- W4313463607 hasAuthorship W4313463607A5019840134 @default.
- W4313463607 hasAuthorship W4313463607A5034266315 @default.
- W4313463607 hasAuthorship W4313463607A5034452160 @default.
- W4313463607 hasAuthorship W4313463607A5036948844 @default.
- W4313463607 hasAuthorship W4313463607A5042451856 @default.
- W4313463607 hasAuthorship W4313463607A5050077108 @default.
- W4313463607 hasAuthorship W4313463607A5056676767 @default.
- W4313463607 hasAuthorship W4313463607A5069311354 @default.
- W4313463607 hasAuthorship W4313463607A5073746039 @default.
- W4313463607 hasBestOaLocation W43134636071 @default.
- W4313463607 hasConcept C120665830 @default.
- W4313463607 hasConcept C121332964 @default.
- W4313463607 hasConcept C126322002 @default.
- W4313463607 hasConcept C168563851 @default.
- W4313463607 hasConcept C203092338 @default.
- W4313463607 hasConcept C2776694085 @default.
- W4313463607 hasConcept C2779802037 @default.
- W4313463607 hasConcept C2779924295 @default.
- W4313463607 hasConcept C2780401358 @default.
- W4313463607 hasConcept C2780580376 @default.
- W4313463607 hasConcept C2780852908 @default.
- W4313463607 hasConcept C2780884295 @default.
- W4313463607 hasConcept C2781112942 @default.
- W4313463607 hasConcept C42219234 @default.
- W4313463607 hasConcept C61511704 @default.
- W4313463607 hasConcept C71924100 @default.
- W4313463607 hasConcept C90924648 @default.
- W4313463607 hasConceptScore W4313463607C120665830 @default.
- W4313463607 hasConceptScore W4313463607C121332964 @default.
- W4313463607 hasConceptScore W4313463607C126322002 @default.
- W4313463607 hasConceptScore W4313463607C168563851 @default.
- W4313463607 hasConceptScore W4313463607C203092338 @default.
- W4313463607 hasConceptScore W4313463607C2776694085 @default.
- W4313463607 hasConceptScore W4313463607C2779802037 @default.
- W4313463607 hasConceptScore W4313463607C2779924295 @default.
- W4313463607 hasConceptScore W4313463607C2780401358 @default.
- W4313463607 hasConceptScore W4313463607C2780580376 @default.
- W4313463607 hasConceptScore W4313463607C2780852908 @default.
- W4313463607 hasConceptScore W4313463607C2780884295 @default.
- W4313463607 hasConceptScore W4313463607C2781112942 @default.
- W4313463607 hasConceptScore W4313463607C42219234 @default.
- W4313463607 hasConceptScore W4313463607C61511704 @default.
- W4313463607 hasConceptScore W4313463607C71924100 @default.
- W4313463607 hasConceptScore W4313463607C90924648 @default.
- W4313463607 hasLocation W43134636071 @default.
- W4313463607 hasOpenAccess W4313463607 @default.
- W4313463607 hasPrimaryLocation W43134636071 @default.
- W4313463607 hasRelatedWork W161558341 @default.
- W4313463607 hasRelatedWork W1824703102 @default.
- W4313463607 hasRelatedWork W1997357590 @default.
- W4313463607 hasRelatedWork W2039989837 @default.
- W4313463607 hasRelatedWork W2084402533 @default.
- W4313463607 hasRelatedWork W2411848747 @default.
- W4313463607 hasRelatedWork W2414252117 @default.
- W4313463607 hasRelatedWork W2972346832 @default.
- W4313463607 hasRelatedWork W4320923492 @default.
- W4313463607 hasRelatedWork W2338742873 @default.
- W4313463607 isParatext "false" @default.
- W4313463607 isRetracted "false" @default.
- W4313463607 workType "article" @default.